Economic Evaluation of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Immune Tolerance Induction (ITI) in Patients with Hemophilia a WHO Develop Inhibitors Under the Brazilian Unified Health System (SUS) Perspective
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1695
https://www.valueinhealthjournal.com/article/S1098-3015(18)32017-5/fulltext
Title :
Economic Evaluation of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Immune Tolerance Induction (ITI) in Patients with Hemophilia a WHO Develop Inhibitors Under the Brazilian Unified Health System (SUS) Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32017-5&doi=10.1016/j.jval.2018.04.1695
First page :
Section Title :
Open access? :
No
Section Order :
920